Literature DB >> 177036

Treatment of transplanted rat tumours with double-stranded RNA(BRL 5907). II. Treatment of pleural and peritoneal growths.

M V Pimm, R W Baldwin.   

Abstract

Intrapleural growth of transplanted rat tumours was prevented or retarded by intrapleural administration of double-stranded RNA. A similar suppression of growth was achieved with peitoneal tumours by the intraperitoneal injection of the compound. These studies indicate the possible potential of this form of treatment of thoracic and peritoneal tumours for clinical application in the treatment of mesothelioma.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 177036      PMCID： PMC2024947          DOI： 10.1038/bjc.1976.21

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  6 in total

1.  Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin.

Authors:  B Zbar; I D Bernstein; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1971-04       Impact factor: 13.506

2.  Antitumour evaluation of a ribonuclease resistant double-stranded RNA-polyquaternary ammonium complex (BRL 10739).

Authors:  J Heyes; E J Catherall; M R Harnden
Journal:  Eur J Cancer       Date:  1974-07       Impact factor: 9.162

3.  Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas.

Authors:  R W Baldwin; M V Pimm
Journal:  Rev Eur Etud Clin Biol       Date:  1971-11

4.  The delayed rejection of tumors formed from the administration of tumor cells mixed with killed Corynebacterium parvum.

Authors:  V V Likhite; B N Halpern
Journal:  Int J Cancer       Date:  1973-11-15       Impact factor: 7.396

5.  Proceedings: Role of immunocompetence in localized BCG suppression of tumour growth.

Authors:  M V Pimm; D G Hopper
Journal:  Br J Cancer       Date:  1975-08       Impact factor: 7.640

6.  Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA.

Authors:  I Parr; E Wheeler; P Alexander
Journal:  Br J Cancer       Date:  1973-05       Impact factor: 7.640
  6 in total
  5 in total

1.  Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNA.

Authors:  B Leticia Rodriguez; Xinran Li; Kaoru Kiguchi; John DiGiovanni; Evan C Unger; Zhengrong Cui
Journal:  Nanomedicine (Lond)       Date:  2012-02-02       Impact factor: 5.307

2.  Antitumor activity of tumor-targeted RNA replicase-based plasmid that expresses interleukin-2 in a murine melanoma model.

Authors:  B Leticia Rodriguez; Jorge M Blando; Dharmika S P Lansakara-P; Yuriko Kiguchi; John DiGiovanni; Zhengrong Cui
Journal:  Mol Pharm       Date:  2013-05-17       Impact factor: 4.939

3.  Replicase-based plasmid DNA shows anti-tumor activity.

Authors:  B Leticia Rodriguez; Zhen Yu; Woon-Gye Chung; Richard Weiss; Zhengrong Cui
Journal:  BMC Cancer       Date:  2011-03-28       Impact factor: 4.430

4.  Treatment of transplanted rat tumours with double-stranded RNA (BRL 5907). I. Influenced of systemic and local administration.

Authors:  M V Pimm; M J Embleton; R W Baldwin
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640

Review 5.  Biological basis for novel mesothelioma therapies.

Authors:  Joanna Obacz; Henry Yung; Marie Shamseddin; Emily Linnane; Xiewen Liu; Arsalan A Azad; Doris M Rassl; David Fairen-Jimenez; Robert C Rintoul; Marko Z Nikolić; Stefan J Marciniak
Journal:  Br J Cancer       Date:  2021-07-05       Impact factor: 9.075
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.